Klineo

Accelerate the recruitment of your clinical trials in oncology

Klineo identifies eligible patients nationwide thanks to its extensive network of oncologists and patients.

They trust us

Institut Gustave Roussy
LYSARC
UCBG
AstraZeneca
MSD
Servier
Roche
Bayer
Pfizer
Collectif Triplettes
1310
GCC
Paris Santé Campus
PSCC
Bpifrance
Tech Paris
Pfizer Healthcare Hub
Pierre Fabre
ONCO
OVHcloud
Institut Gustave Roussy
LYSARC
UCBG
AstraZeneca
MSD
Servier
Roche
Bayer
Pfizer
Collectif Triplettes
1310
GCC
Paris Santé Campus
PSCC
Bpifrance
Tech Paris
Pfizer Healthcare Hub
Pierre Fabre
ONCO
OVHcloud

A proven recruitment accelerator

Klineo makes it easier to refer patients to their trials thanks to a network of committed oncologists and a precision algorithm.

up to

+25 %

recruitment acceleration

thanks to

+3 000

healthcare professionals active on Klineo

present in

4 countries

France, Belgium, Italy, Germany

Centers using Klineo

+500 partner centers

Klineo’s strengths for sponsors

Network

A tool massively adopted by physicians

More than 3,000 healthcare professionals use Klineo every day to refer their patients to the most appropriate clinical trials. A network that grows every week and refers directly to your investigator sites.

Network of healthcare professionals
+38 this week
3 000+
healthcare professionals
550
referring centers
AI algorithm

The best patient / trial matching algorithm

Powered by the latest-generation LLM models, our algorithm analyzes all the discriminating clinical criteria to identify the patients eligible for your trials. Unmatched sensitivity and specificity, validated in Nature.

Read the scientific article
Patient
Mr Bernard · Lung · PD-L1+
vs
Trial
PhAST-02 · Phase 3
AI analysis criterion by criterion
Histological typeEligible
PD-L1 biomarkerTo verify
Treatment lineNot eligible
Analytics

Steer your recruitment with real-time data

Understand the referral flows around your investigator sites. Identify the blocking criteria that slow down your inclusions. Anticipate deviations from your recruitment targets, and act without delay.

Inclusion rate
Trial PhAST-02
68 %
Reasons for non-inclusion
Biomarker not mutated34%
Stage too advanced26%
Comorbidity22%
Outside age criterion18%
Source of referrals

Data security

The management and security of user data are at the heart of Klineo's priorities.

GDPR compliant

Klineo is supported by a law firm specialized in GDPR compliance and health data management.

Storage on certified servers for health data

All Klineo data is stored on servers in France by a French supplier approved HDS (Health Data Host) by the Ministry of Health and certified ISO27001, ISO9001 and ISO14001.

Data protection officer

The role of DPO (Data Protection Officer) is provided by DrData, an actor specialized in health data.

Ready to recruit faster?

Join the pharmaceutical companies already using Klineo to accelerate their oncology trials. Our team will walk you through the platform in 30 minutes.